Neuropsychiatric disorders at the presentation of type 2 diabetes mellitus in children (Q36166349)

12 August 2017

Neuropsychiatric disorders at the presentation of type 2 diabetes mellitus in children (English)

1 reference

12 August 2017

0 references

Lorraine E Levitt Katz

1

1 reference

12 August 2017

Sanjeev Swami

2

1 reference

12 August 2017

Máire Abraham

3

1 reference

12 August 2017

Kathryn M Murphy

4

1 reference

12 August 2017

Abbas F Jawad

5

1 reference

12 August 2017

Heather McKnight-Menci

6

1 reference

12 August 2017

Robert Berkowitz

7

1 reference

12 August 2017

1 June 2005

1 reference

12 August 2017

1 reference

12 August 2017

6

1 reference

12 August 2017

84-89

1 reference

12 August 2017

2

1 reference

Type 2 diabetes mellitus in children and youth: a new epidemic

12 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

A prospective study of the role of depression in the development and persistence of adolescent obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Drug-induced hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Drug-induced disorders of glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Clozapine-associated diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Olanzapine-associated diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Drugs that cause weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Effects of Nefazodone on Body Weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Prevalence and development of psychiatric disorders in childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Behavioural phenotypes associated with specific genetic disorders: evidence from a population-based study of people with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Aerobic capacity, weight gain and psychotropic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

Abnormalities in glucose regulation associated with mental illness and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-543X.2005.00105.X

10.1111/J.1399-543X.2005.00105.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference